| Literature DB >> 33647234 |
Zhi Zhang1,2, Jae Whan Park1,2, In Sook Ahn1, Graciel Diamante1, Nilla Sivakumar1,2, Douglas Arneson1, Xia Yang1, J Edward van Veen1,2, Stephanie M Correa1,2.
Abstract
Adjuvant tamoxifen therapy improves survival in breast cancer patients. Unfortunately, long-term treatment comes with side effects that impact health and quality of life, including hot flashes, changes in bone density, and fatigue. Partly due to a lack of proven animal models, the tissues and cells that mediate these negative side effects are unclear. Here, we show that mice undergoing tamoxifen treatment experience changes in temperature, bone, and movement. Single-cell RNA sequencing reveals that tamoxifen treatment induces widespread gene expression changes in the hypothalamus and preoptic area (hypothalamus-POA). These expression changes are dependent on estrogen receptor alpha (ERα), as conditional knockout of ERα in the hypothalamus-POA ablates or reverses tamoxifen-induced gene expression. Accordingly, ERα-deficient mice do not exhibit tamoxifen-induced changes in temperature, bone, or movement. These findings provide mechanistic insight into the effects of tamoxifen on the hypothalamus-POA and indicate that ERα mediates several physiological effects of tamoxifen treatment in mice.Entities:
Keywords: bone; cancer biology; estrogen receptor alpha; hypothalamus; mouse; neuroscience; physical activity; tamoxifen; thermoregulation
Mesh:
Substances:
Year: 2021 PMID: 33647234 PMCID: PMC7924955 DOI: 10.7554/eLife.63333
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140